In 2019, the top 10 therapeutic classes accounted for 76.8% of all scripts and 79.6% of all costs. An understanding of the most-utilized and highest-ranked classes of medications by cost can drive intervention opportunities and benchmark targeted efforts for pharmacy program management. Year-over-year trend changes can also guide decision-making and identify drug class utilization and cost outliers that may warrant further evaluation for appropriateness and safety.
Watch the video blog here.
Will GLP-1 weight loss drugs become more prevalent in workers’ compensation? Glucagon-like peptide 1 (GLP-1)
As the workers' compensation and auto industry braces itself for the regulatory changes sweeping across Michigan, Florid
Beyond convenience, reliable transportation prevents missed appointments that can delay recovery and worsen health outcomes.
May/June 2024 Kontos Kommentary The following commentary is produced by Tom Kontos, Chief Economist, ADESA Auctions.
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dive deeper into part
For over three decades, early intervention telephoni
